Sutro Biopharma, Inc.Sutro Biopharma, Inc.Sutro Biopharma, Inc.

Sutro Biopharma, Inc.

No trades
See on Supercharts

Price target

12.000.000.00%
The 10 analysts offering 1 year price forecasts for STRO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to STRO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


STRO EPS for the last quarter is −0.59 USD despite the estimation of −0.73 USD. In the next quarter EPS is expected to reach −0.83 USD. Track more of Sutro Biopharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Sutro Biopharma, Inc. revenue is expected to reach ‪12.15 M‬ USD. Check out Sutro Biopharma, Inc. revenue and earnings and make informed decisions.
According to analysts, STRO price target is 12.00 USD with a max estimate of 20.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Sutro Biopharma, Inc. stock price chart and keep track of the current situation with STRO news and stock market news.
We've gathered opinions of 11 analysts rating STRO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.